How the AI revolution can accelerate early drug discovery
Drug Target Review
SEPTEMBER 20, 2023
Training AI/ML tools to predict results of otherwise complex and time-consuming calculations is gaining traction in pharmaceutical R&D. To really benefit from AI, the pharmaceutical industry must be more open to data sharing. He has published 22 scientific articles and has a h-index of 13. Matthew is a chartered chemist.
Let's personalize your content